BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35712914)

  • 1. Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy.
    Fontana G; Barcellini A; Boccuzzi D; Pecorilla M; Loap P; Cobianchi L; Vitolo V; Fiore MR; Vai A; Baroni G; Preda L; Imparato S; Orlandi E
    Future Oncol; 2022 Jul; 18(22):2403-2412. PubMed ID: 35712914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?
    van Heeswijk MM; Lambregts DMJ; Maas M; Lahaye MJ; Ayas Z; Slenter JMGM; Beets GL; Bakers FCH; Beets-Tan RGH
    Abdom Radiol (NY); 2017 Jun; 42(6):1627-1636. PubMed ID: 28160039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating locally recurrent rectal cancer from scar tissue: Value of diffusion-weighted MRI.
    Grosu S; Schäfer AO; Baumann T; Manegold P; Langer M; Gerstmair A
    Eur J Radiol; 2016 Jul; 85(7):1265-70. PubMed ID: 27235873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma.
    Chidambaram V; Brierley JD; Cummings B; Bhayana R; Menezes RJ; Kennedy ED; Kirsch R; Jhaveri KS
    Abdom Radiol (NY); 2017 May; 42(5):1310-1318. PubMed ID: 28004138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI.
    Petrillo A; Fusco R; Granata V; Setola SV; Sansone M; Rega D; Delrio P; Bianco F; Romano GM; Tatangelo F; Avallone A; Pecori B
    Med Oncol; 2017 Nov; 34(12):198. PubMed ID: 29151142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
    Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
    Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-irradiation With Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis.
    Barcellini A; Vitolo V; Cobianchi L; Peloso A; Vanoli A; Mirandola A; Facoetti A; Fiore MR; Iannalfi A; Vischioni B; Cuccia F; Ronchi S; Bonora M; Riva G; Petrucci R; D'Ippolito E; Mas FD; Preda L; Valvo F
    In Vivo; 2020; 34(3):1547-1553. PubMed ID: 32354961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer.
    Delli Pizzi A; Caposiena D; Mastrodicasa D; Trebeschi S; Lambregts D; Rosa C; Cianci R; Seccia B; Sessa B; Di Flamminio FM; Chiacchiaretta P; Caravatta L; Cinalli S; Di Sebastiano P; Caulo M; Genovesi D; Beets-Tan R; Basilico R
    Abdom Radiol (NY); 2019 Nov; 44(11):3595-3605. PubMed ID: 31444557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer.
    Cai X; Li P; Zhao J; Wang W; Cheng J; Zhang G; Cai S; Zhang Z; Jiang G; Zhang Q; Wang Z
    J Radiat Res; 2023 Nov; 64(6):933-939. PubMed ID: 37738440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
    Zhao M; Zhao L; Yang H; Duan Y; Li G
    Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of diffusion-weighted imaging in rectal cancer.
    Intven M; Reerink O; Philippens ME
    J Magn Reson Imaging; 2014 Jul; 40(1):146-50. PubMed ID: 24127172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    De Felice F; Magnante AL; Musio D; Ciolina M; De Cecco CN; Rengo M; Laghi A; Tombolini V
    Eur J Surg Oncol; 2017 Jul; 43(7):1324-1329. PubMed ID: 28363512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
    Cai G; Xu Y; Zhu J; Gu WL; Zhang S; Ma XJ; Cai SJ; Zhang Z
    World J Gastroenterol; 2013 Sep; 19(33):5520-7. PubMed ID: 24023496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidance of magnetic resonance imaging for target area delineation of postoperative presacral recurrence of rectal cancer].
    Li XN; Liu T; Wang C; Guo P; Ye YJ; Chen YL; Cheng J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1170-1176. PubMed ID: 33353272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.